(HR) Healthcare Realty Trust - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4219461047
HR: Medical Buildings, Outpatient Facilities, Healthcare Properties
Healthcare Realty Trust Incorporated (NYSE: HR) stands as a prominent figure in the real estate investment trust (REIT) sector, specializing in medical outpatient facilities strategically positioned near leading hospital campuses. This strategic placement underscores their focus on capturing the demand for convenient, high-quality outpatient care, a sector experiencing growth as healthcare increasingly shifts towards outpatient services.
Their portfolio is both extensive and specialized, comprising over 650 properties that span nearly 40 million square feet across 15 growth markets. This concentration in key areas highlights their commitment to areas with high potential for expansion and demand in healthcare services, positioning them as a leader in their niche.
Growth for Healthcare Realty is achieved through a balanced approach of acquisitions and development, allowing them to expand their footprint while maintaining a focus on quality and strategic fit. Their position as the first and largest REIT in this specialized sector speaks to their expertise and market understanding, crucial for investors seeking stability and growth in the healthcare real estate sector.
From a financial standpoint, Healthcare Realty presents an intriguing profile with a market capitalization of approximately $5.9 billion, offering investors a substantial and established player in the market. Their forward P/E ratio of 10.83 suggests expectations for moderate growth, while a P/S ratio of 4.60 indicates a premium valuation relative to their revenue, reflecting the markets confidence in their business model and growth prospects.
In summary, Healthcare Realty Trust offers a compelling blend of sector expertise, strategic portfolio management, and financial stability, making it a notable consideration for investors and fund managers looking to tap into the growing healthcare real estate market.
Additional Sources for HR Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
HR Stock Overview
Market Cap in USD | 5,831m |
Sector | Real Estate |
Industry | REIT - Healthcare Facilities |
GiC Sub-Industry | Health Care REITs |
IPO / Inception | 1993-05-26 |
HR Stock Ratings
Growth 5y | 11.3% |
Fundamental | 9.50% |
Dividend | 60.8% |
Rel. Strength Industry | 23.4 |
Analysts | 2.82/5 |
Fair Price Momentum | 18.00 USD |
Fair Price DCF | 16.64 USD |
HR Dividends
Dividend Yield 12m | 7.55% |
Yield on Cost 5y | 8.58% |
Annual Growth 5y | 0.66% |
Payout Consistency | 81.8% |
HR Growth Ratios
Growth Correlation 3m | -14.1% |
Growth Correlation 12m | 54.5% |
Growth Correlation 5y | -14.3% |
CAGR 5y | 2.44% |
CAGR/Max DD 5y | 0.05 |
Sharpe Ratio 12m | -0.18 |
Alpha | 24.75 |
Beta | 0.54 |
Volatility | 22.57% |
Current Volume | 2994.2k |
Average Volume 20d | 2624.1k |
As of March 14, 2025, the stock is trading at USD 16.31 with a total of 2,994,248 shares traded.
Over the past week, the price has changed by -1.21%, over one month by +0.31%, over three months by -3.54% and over the past year by +31.13%.
Neither. Based on ValueRay Fundamental Analyses, Healthcare Realty Trust is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 9.50 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HR as of March 2025 is 18.00. This means that HR is currently undervalued and has a potential upside of +10.36% (Margin of Safety).
Healthcare Realty Trust has received a consensus analysts rating of 2.82. Therefor, it is recommend to hold HR.
- Strong Buy: 1
- Buy: 0
- Hold: 8
- Sell: 0
- Strong Sell: 2
According to ValueRays Forecast Model, HR Healthcare Realty Trust will be worth about 19.4 in March 2026. The stock is currently trading at 16.31. This means that the stock has a potential upside of +19.19%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 17.8 | 9% |
Analysts Target Price | 18 | 10.4% |
ValueRay Target Price | 19.4 | 19.2% |